Trials / Completed
CompletedNCT06174207
Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Eastern Switzerland University of Applied Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chronic respiratory diseases are a global burden. Treatment options have improved in recent years, pulmonary rehabilitation plays a key role. Oxygen therapy is recommended in patients with a low saturation at rest, but no clear guidance is given for patients who desaturate during exercise. The effect of ambulatory oxygen during exercise is not yet completely understood, especially in those patients with exercise-induced desaturation. Aim: The goal of this study is to analyse the effect of supplemental oxygen given during a constant work rate exercise test (CWRET) on a cycle ergometer compared to sham air. Methods: We plan to include 25 Patients respiratory patients undergoing pulmonary rehabilitation (male and female; aged \>18 years; stable condition \>3 weeks (e.g. no exacerbations); resting oxygen saturation (SpO2) ≥ 88%) with exercise induced hypoxemia defined by a fall in oxygen saturation by ≥ 4% during a 6-minute walking test. Patients will undergo an incremental exercise test with a ramp protocol (for evaluating the maximal workload) and two CWRET (75% of the maximal workload) with ambulatory oxygen or placebo (sham air) via standard nasal canula at a flow rate of 5l/min. Patients and assessors will be blinded. The difference endurance time of the CWRET with oxygen vs. sham air will be the primary outcome of this study. Data will be summarized by means (SD) and medians (quartiles) for normal and non-normal distributions. Effects of treatment will be evaluated by mean differences with 95% confidence intervals, T-tests or Wilcoxon matched pair tests as appropriate. A p-value threshold of \<0.05 or a confidence interval not including zero will be considered as statistically significant. Analyses will be performed according to the intention to treat principle.
Conditions
- Chronic Obstructive Pulmonary Disease
- Asthma
- Pulmonary Hypertension
- Interstitial Lung Disease
- Chronic Lung Disease
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oxygen | Standard supplemental Oxygen therapy (5l/min) will be applied with an oxygen concentrator via nasal cannula. |
Timeline
- Start date
- 2024-01-24
- Primary completion
- 2025-01-01
- Completion
- 2025-01-17
- First posted
- 2023-12-18
- Last updated
- 2025-08-12
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06174207. Inclusion in this directory is not an endorsement.